Primary heart involvement in systemic sclerosis, from conventional to innovative targeted therapeutic strategies.

IF 1.4 Q3 RHEUMATOLOGY
Arianna Ferlito, Corrado Campochiaro, Alessandro Tomelleri, Lorenzo Dagna, Giacomo De Luca
{"title":"Primary heart involvement in systemic sclerosis, from conventional to innovative targeted therapeutic strategies.","authors":"Arianna Ferlito,&nbsp;Corrado Campochiaro,&nbsp;Alessandro Tomelleri,&nbsp;Lorenzo Dagna,&nbsp;Giacomo De Luca","doi":"10.1177/23971983221083772","DOIUrl":null,"url":null,"abstract":"<p><p>Primary heart involvement is frequent in systemic sclerosis, even though often sub-clinical, and includes cardiac abnormalities that are predominantly attributable to systemic sclerosis rather than other causes and/or complications. A timely diagnosis is crucial to promptly start the appropriate therapy and to prevent the potential life-threatening early and late complications. There is little evidence on how to best manage systemic sclerosis-primary heart involvement as no specific treatment recommendations for heart disease are available, and a shared treatment approach is still lacking. The objective of this review is to summarize the state of the art of current literature and the overall management strategies and therapeutic approaches for systemic sclerosis-primary heart involvement. Novel insights into pathogenic mechanisms of systemic sclerosis-primary heart involvement are presented to facilitate the comprehension of therapeutic targets and novel treatment strategies.</p>","PeriodicalId":17036,"journal":{"name":"Journal of Scleroderma and Related Disorders","volume":null,"pages":null},"PeriodicalIF":1.4000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537702/pdf/10.1177_23971983221083772.pdf","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Scleroderma and Related Disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/23971983221083772","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/3/24 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 3

Abstract

Primary heart involvement is frequent in systemic sclerosis, even though often sub-clinical, and includes cardiac abnormalities that are predominantly attributable to systemic sclerosis rather than other causes and/or complications. A timely diagnosis is crucial to promptly start the appropriate therapy and to prevent the potential life-threatening early and late complications. There is little evidence on how to best manage systemic sclerosis-primary heart involvement as no specific treatment recommendations for heart disease are available, and a shared treatment approach is still lacking. The objective of this review is to summarize the state of the art of current literature and the overall management strategies and therapeutic approaches for systemic sclerosis-primary heart involvement. Novel insights into pathogenic mechanisms of systemic sclerosis-primary heart involvement are presented to facilitate the comprehension of therapeutic targets and novel treatment strategies.

系统性硬化症的原发性心脏受累,从传统到创新的靶向治疗策略。
原发性心脏受累在系统性硬化症中很常见,尽管通常是亚临床的,包括主要归因于系统性硬化而非其他原因和/或并发症的心脏异常。及时诊断对于及时开始适当的治疗和预防潜在的危及生命的早期和晚期并发症至关重要。关于如何最好地管理系统性硬化症原发性心脏病,几乎没有证据,因为没有针对心脏病的具体治疗建议,而且仍然缺乏共享的治疗方法。这篇综述的目的是总结当前文献的现状,以及系统性硬化原发性心脏受累的总体管理策略和治疗方法。对系统性硬化原发性心脏受累的致病机制提出了新的见解,以促进对治疗靶点和新的治疗策略的理解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.10
自引率
0.00%
发文量
31
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信